FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage

Rosa Lombardi, Salvatore Petta, Giuseppina Pisano, Paola Dongiovanni, Luca Rinaldi, Luigi Elio Adinolfi, Carlo Acierno, Luca Valenti, Roberta Boemi, Federica Spatola, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani

Research output: Contribution to journalShort survey

Abstract

Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1

Original languageEnglish
Pages (from-to)517-519
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume18
Issue number2
DOIs
Publication statusPublished - Feb 2020

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage'. Together they form a unique fingerprint.

  • Cite this